Edgewise Therapeutics, Inc. EWTX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s interest income?
- Edgewise Therapeutics, Inc. (EWTX) reported interest income of $5.1M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s interest income changed year-over-year?
- Edgewise Therapeutics, Inc.'s interest income decreased by 1.1% year-over-year, from $5.16M to $5.1M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s interest income has grown at a 176.8% compound annual growth rate (CAGR), from $402K to $23.61M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.